News

Two years of Synopsys (SNPS) earnings calls show management changing what it explains. The company used to open on problems, some outside its control and some its own. The August 2026 call is built around a joint product with Ansys, agentic AI, and a new way to charge for its design IP. Most of that switch is earned, but parts of it are still a promise.

Synopsys has seen its share price come under pressure this year, which puts a sharper spotlight on whether the current market value lines up with the cash the business is expected to generate. With the stock now trading well below where it started the year, investors are increasingly asking if the recent slide has reset expectations or if the price is still leaning on optimistic assumptions about future cash flows. The share price is down about 20.7% year to date, which makes the link...

Autodesk (ADSK) stock has 23.6% of room above it before it meets a ceiling that has turned it back three times, and 5% below it before the reason to be there stops being true. In dollars: $272.34 overhead, $220.31 Wednesday, $209.29 underneath. The stock has lost about 31% over the past twelve months, so the easy read is that the business broke. Its own numbers say it did not.

Shares of quantum computing company IonQ (NYSE:IONQ) jumped 10.1% in the afternoon session after the company announced joint research with Synopsys showing that quantum algorithms accelerated industrial design simulations by up to 14.6%. According to a company press release, the work embedded an advanced quantum algorithm into Synopsys’s Ansys LS-DYNA simulation software to reorganize equations more efficiently and cut calculation time for complex automotive and jet-engine simulations. IonQ said

IonQ made a breakthrough. It doesn't make IonQ stock a buy, however.

Based on the average brokerage recommendation (ABR), Synopsys (SNPS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Synopsys (SNPS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Cadence Design Systems (CDNS) trades at 54.5 times trailing earnings. A multiple that high is a requirement rather than an opinion. The price only works if the business grows into it, and you can work out exactly how much growth it takes. The harder question is whether that calculation deserves your trust here.

Micron stock was reacting to news that Intel and SK Hynix are discussing U.S. memory-chip manufacturing.

IonQ received four Best Paper Awards ahead of IEEE Quantum Week 2026, highlighting research with commercial and institutional partners across artificial intelligence, engineering and life sciences. Key Investor TakeawaysIonQ (NYSE:IONQ) received four Best Paper Awards from 857 global research submissions ahead of IEEE Quantum Week 2026.

Synopsys (SNPS) trades near $400, and the options market has already drawn the boundaries it expects the stock to hold over roughly the next twelve months: about $251 at the floor and about $630 at the ceiling. That is a very wide year to be holding a single name. What matters is that for this stock, a range that wide is ordinary.

IonQ is presenting nine peer-reviewed papers at IEEE Quantum Week 2026, including four Best Paper Award recipients, with research spanning quantum machine learning, industrial simulation, protein folding, logistics and quantum error reduction. Key Investor TakeawaysIonQ (NYSE:IONQ) has nine peer-reviewed papers accepted for QCE26, with four receiving Best Paper Awards.

Arm sits underneath nearly every hyperscaler custom CPU program, collecting royalty checks as AI infrastructure spending accelerates, but its 120x forward multiple means a single stumble could trigger violent downside for a stock already swinging between $223 and $420.

Synopsys has taken a beating this year while its fundamentals moved sharply in the opposite direction, and that gap between price and earnings power is exactly where our model tends to find its best setups.

Synopsys (SNPS) trades about 26% below its 52-week high after falling about 34% over the past year. You can be paid now to agree to buy it well below today's price, and you keep that payment either way. The catch is that you must want the business. One analyst says investors constantly ask whether AI could disrupt the kind of software Synopsys sells, and that a school of thought asks whether AI could design chips end to end without it.

Synopsys (SNPS) sells chip design and verification software, and its revenue is now growing more than four times faster than its own long-run pace. The share price has done the opposite. For anyone holding it, one question is worth settling: is this new speed the pace you now own the company for.

Investing.com -- Morgan Stanley has taken a more selective stance on European semiconductor stocks, staying positive on the sector overall while adjusting ratings and price targets as the memory cycle nears a turn and valuations diverge.

Both software players are riding the AI wave, but PTC offers a clearer forward path with stronger growth and profitability, while Oracle asks investors to fund a massive, costly buildout.

The design software giant is betting on a new strategy, and its stock history offers a strong blueprint for buying on weakness.

Synopsys powers nearly every advanced chip on the planet, yet its stock has cratered while the broader market surged, and Wall Street analysts are betting that gap closes in a hurry.

Synopsys (SNPS) booked revenue of $2.477 billion in fiscal Q3 2026, up about 42% year over year, and the shares have still lost about 30% over the past twelve months. Look past that headline at the line underneath it: EDA grew 8.5%. That single-digit number is the pace of the design tools business Synopsys had before the Ansys deal.

Marvell and Synopsys both profit from the AI chip boom, but one company is quietly handing hyperscalers the tools to cut the other out entirely. The tension between them reveals something uncomfortable about where custom silicon money actually flows.

Synopsys stock presents a clear valuation split for investors. The intrinsic value estimate from a Discounted Cash Flow (DCF) approach points to a discount to current trading levels, while market based multiples and a low overall value score suggest the shares are not obviously cheap. Over the past 1 year the share price has fallen 29.9%, which means investors are assessing Synopsys after a meaningful reset rather than at a recent peak. Stronger demand for Synopsys tools linked to AI and...

Imagine two very different futures for your Autodesk (ADSK) stock a year from now. In one, it’s trading near $165. In the other, it’s pushing past $402.44. The options market isn’t picking a winner; it’s telling you that both are plausible destinations. For a shareholder, that’s not a theoretical exercise. It’s the risk you already own.

AI's memory crunch could extend through 2027, driving chipmakers while pressuring electronics firms. Which ETFs could emerge as winners?

Jensen Huang turned a modest chip startup into the backbone of the global AI arms race, and his personal fortune now rivals the biggest names in tech. But three mounting challenges could test whether Nvidia's reign at the top is as unshakeable as it appears.

Synopsys just posted explosive revenue growth that dwarfs its closest EDA rival, yet the market prices it at a fraction of that rival's multiple. Something in that gap tells a story most investors are missing.

The mean of analysts' price targets for Synopsys (SNPS) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.